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Introduction
Databases with patient health information have been
used for a long time and have not been considered to cre-
ate any problems. Databases have been used in various
ways such as for quality control and research and health
authorities have for some time used databases for citizen
health information. It is important for example for the au-
thorities to have information on infectious diseases that
may cause much distress in society. Each database has a
delimited and defined purpose even though in many cas-
es they contain a large amount of information. Institu-
tions have been established to issue licenses for databases
(Data Commissions) and to ensure that the data is cor-
rectly used (Ethical Committees). Their use has not how-
ever been much discussed in open forums in recent years.
Iceland has a long tradition for the use of databases with
health information as in other Western societies and they
have not been questioned. The public has been confident
that their information is used correctly and has been given
no reason to think otherwise. Institutions have been set
up to control them like in other countries and apparently
the control has been effective.
Proposal for a central health database in Iceland
In the spring of 1998 a bill was introduced for a central
health sector database. It stipulated that all health infor-
mation produced in the communication of physicians
with all the country's patients be entered in a single data-
base. It was also planned that all other health information
created in health institutions be transferred to the data-
base. At the same time it was introduced that this large da-
tabase would be in charge of a private company that
would have an exclusive right for the use of this informa-
tion for a long time. Nothing was known of this plan until
the bill was ready for parliamentary debate so that there
had been no discussion among physicians, scientists, pol-
iticians or among the general public. It was as if a bomb
had been thrown into the small Icelandic society and
what followed was a great and heated debate which was to
a large extent concerned with ethics and citizens' rights.
Due to the criticism that emerged the bill was withdrawn
from parliament in the spring session in spite of the fact
that it was a government bill with a sizable majority in the
sitting parliament. The bill was presented again in the au-
tumn with some alterations and passed as legislation in
December of 1998. A year later an agreement was made
with DeCode Genetics concerning the operations of the
database and the company got a 12 year exclusive right of
operation. It has however proved very complicated to es-
tablish the database and it is still not ready.
Why were the company and the government so interested
in the case and which issues were most debated? The idea
was to gather as much information on the health of one
nation as possible and then use data mining without a
predetermined hypothesis to find connections between
different sources of information in a manner that would
not otherwise be possible. What made the database partic-
ularly valuable were possibilities to connect it to a data-
base with genealogical information on all Icelanders.
Today the genealogical database contains the names and
genealogy of 680,000 Icelanders of the approximately one
million that have lived in the past 1100 years. In addition
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the company had gathered genetic information with
blood samples from tens of thousands of inhabitants
which were possible to connect to the health information.
One reason why the idea was criticised so strongly and the
debate became so heated was the speed with which the
case was to be dealt with. Physicians and scientists were
given no opportunity to discuss the issue before it was pre-
sented to parliament and a short time given for discussion
there. There was also limited information on many im-
portant points such as which information was to be en-
tered in the database, how far back in time information
was to be sought, how it was to be used and where lay the
great estimated cost (one hundred million pounds ster-
ling). Issues of patient rights and whether others should
be able to use the database were also debated.
The law stipulates that all information be entered into the
database except from those patients who provide a written
statement that they do not want it (presumed consent).
This means in fact that only those who are most con-
cerned about the issue will have such an initiative. Parents
have the authority on behalf of their children but no one
can oppose on behalf of the deceased. There is already be-
fore the courts a case of a young woman who does not
want information on her deceased father to be entered in
the database. The case was lost in a lower court and is now
before the Supreme Court. It is expected that other issues
will be tried before the courts. Most patients with mental
illness and senility have a legal capacity and no one can
oppose on their behalf. From the outset the Icelandic
Medical Association (IcMA) took part in the discussion
and has lead the criticism. Soon the main emphasis was
placed on the issue of consent, i.e. that each individual be
asked his opinion (informed consent) but other issues
were considered as well. In this effort the association has
sought the opinion of various parties domestically and
abroad, among others on the issue of security. For this rea-
son the association engaged in major disputes with Icelan-
dic health authorities and DeCode: Soon it became clear
that the ministry and the ruling parties did not mean to
make any changes to legislation or the following regula-
tion but DeCode was willing to reach a joint ethical vision
of the database and talks began. Progress was slow with
periods of no talks but last year an agreement was reached.
The IcMA and DeCode agreed on two major points relat-
ing to deleting data already entered and that the database
abide by the statement on health sector databases to be
agreed by the World Medical Association (WMA).
The WMA statement
Why is it necessary to relate in such detail a discussion in
one of the world's smallest societies and how does it con-
cern other societies? The answer is mainly that the IcMA
soon presented its views abroad, both to the Nordic med-
ical associations and within the WMA. This has lead the
WMA to deal specially with the ethics of databases, as the
ethics of medical science has been one of the association's
main tasks from the beginning. Thereby the issue of data-
bases with health information has become the issue of all
medical associations within the WMA. A workgroup was
appointed in 2000 to work on a declaration in this field to
be presented at the association's annual meeting in the au-
tumn of 2002. It is hoped that the declaration will be
agreed on as the policy of the WMA marking the course in
that field for years to come.
The WMA has mostly completed its work on the declara-
tion and it will contain certain basic principles. Most of
them are to be found in the association's earlier state-
ments such as the Declaration of Lisbon on the Rights of
the Patient, the Declaration of Geneva (International
Code of Medical Ethics) and the Declaration of Helsinki
(Recommendations Guiding Physicians in Biomedical Re-
search Involving Human Subjects). The main points re-
garding patients' rights are:
1. The right to be informed. Patients should be informed
if information on them is to be made available to a third
party. This information should be provided even in in-
stances when the patient cannot oppose the use of his
health information.
2. A person's right to oppose the use of that information.
There will be a general rule that a patient can oppose the
transfer of information on him to an indicated database
and only in exceptional cases will he be unable to oppose.
3. The right to consent. Only in exceptional cases would
information be transferred to a health database without
seeking consent.
4. The right to confidentiality. A patient should be able to
trust that his physician will not give to others information
that the patient gives him in order to be cured of his ills.
5. The right to deletion of data. Should the patient change
his mind he should be able to demand that his data be de-
leted if technically possible.
One of the difficult issues to solve is that patients' rights
regarding the use of health information does not go
against the interest of all. In some instances it is not diffi-
cult to support the interest of all, like health authorities
must be able to monitor infectious diseases that pose a
risk to public health such as tuberculosis and HIV infec-
tion. Databases on cancer have been used for a long time
in some countries without them being questioned.
Should patients have the right to oppose a transfer of in-
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is a widespread use of databases to measure the success of
a treatment in order to increase it (quality control) and in
order for them to be useful it is important that informa-
tion on every patient be registered. In none of these in-
stances can it be asserted that patients providing
information gain directly from the registration and it dif-
fers how easily one can argue for the interest of all even
though it may apply in these examples. The case is differ-
ent for databases that are only used for research. There
seems to be agreement that each patient should be able to
decide whether his information be transferred to a data-
base used for research, such as when patients participate
directly in research, as stated in the Declaration of Helsin-
ki. This leaves two issues to be solved. What about existing
databases with information gathered within the health
system and which are only to be used for research but
where patients were not asked their opinion? What is to
be done about all composed databases, such as those who
are set up for one purpose (e.g. quality control) but are
then used for other purposes such as research? Many of
these points have not been fully discussed but WMA and
are yet to be resolved.
The future of databases
It is said that in the modern information society the key to
power is information. Could it be that the same applies to
health information? There are arguments to support this.
If a database contains information that can be used to pro-
duce sellable material, such as medicine or a new type of
treatment, the owner of that information can gain finan-
cially and even have power to control the progress of
knowledge. It is therefore important to set up a framework
for the ownership, use and access to databases to prevent
abuse. At the same time the individual's right to control
the use of information about him must be ensured. One
of the key questions that has to be asked is whether they
should have the same right if the data cannot be personal-
ised. The European Union standard of personalisation has
been quoted in this respect, where it is indicated that if it
takes a considerable amount of capital and manpower to
personalise information it shall be considered 'unperson-
alisable'. It has been pointed out that technology
progresses fast and sufficient safety today may not be suf-
ficient tomorrow. It is a subject of politics to decide
whether exclusive licenses for extensive databases with
health information should be granted to companies that
are run for profit, but in market driven societies it is likely
to be supported. When setting up databases that are as ex-
tensive for a whole nation as is intended in Iceland the ac-
cess of others to such data bases must also be guaranteed,
both health authorities as other scientists.
The expected WMA declaration will have great influence
on the progress of this cause in international context and
its initiative on the issue is important. The WMA must car-
ry on the experience of the countries that are first to come
across this ethical problem to those that have yet to take it
on. In the years to come the discussion will develop and
the rules applying today will be altered along with new
technologies and new attitudes.
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